ASML Holding N.V. vs. Broadcom: Which Technology Stock Is a Better Buy in 2026?

Broadcom is favored over ASML for a 2026 portfolio, with FY 2025 revenue growth of 23.9% to $63.9B, net income of $23.1B and a 36.2% net margin, versus ASML’s 15.6% revenue growth to $36.6B and $10.8B net income. Broadcom also posted a recent-quarter revenue increase of 85% year over year and a 48.6% operating margin, while its forward P/E was 30.4x versus ASML’s 42.8x; their price-to-sales multiples were similar at 19.0x and 18.2x, respectively. The article notes Broadcom’s customer concentration, acquisition-related debt and regulatory challenges, while ASML faces chip-cycle and export-restriction risks.

Analysis

The comparison favors AVGO on reported growth and earnings multiples, but that may understate the difference in earnings quality: a meaningful SBC add-back makes its cash-flow headline less comparable, while share-count dilution and VMware retention/renewal metrics matter to the equity case. Its networking and custom-chip opportunity is also concentrated in a handful of hyperscaler budgets; if those customers shift spending or bring more silicon design in-house, growth and the valuation premium can compress together. Conversely, ASML’s strategic bottleneck is not easily replicated, but its earnings path is exposed to foundry investment timing and export-policy changes. Order timing can therefore produce a sharp near-term drawdown without necessarily impairing the long-run franchise.

The article’s AVGO-over-ASML conclusion leans on forward estimates and headline profitability, not a demonstrated risk-adjusted valuation advantage. For the next 1–3 months, monitor AVGO’s customer-level AI revenue trajectory, SBC-adjusted per-share cash generation, VMware renewals and channel/regulatory developments; for ASML, prioritize bookings, cancellations and export-rule changes. Over 6–18 months, hyperscaler capex allocation and advanced-node investment are the key relative drivers. A relative-value position is more defensible than treating either name as an uncontested winner.

Key Decisions for Investors

• Do not chase AVGO solely on the reported growth comparison. Consider a staged, beta-aware long ASML / short AVGO pair only if AVGO’s next results show weaker AI customer momentum, rising dilution, or VMware retention/channel pressure while ASML bookings remain resilient. Keep sizing modest: both remain exposed to technology-capex sentiment.
• For AVGO, verify stock-based compensation as a share of operating cash flow alongside diluted share-count growth and free cash flow per share. Strong per-share conversion and sustained customer commitments would falsify the cash-quality concern; weakening hyperscaler guidance would strengthen it.
• For ASML, watch order intake/cancellations and any export-control revisions rather than relying on its bottleneck status alone. A material order deterioration or broader restrictions would undermine the long thesis; continued bookings through a capex pause would support it.
• Near-term catalyst risk is earnings and policy headlines; over 6–18 months, the key test is whether AI infrastructure spending broadens beyond a few buyers and whether advanced-node capacity plans translate into equipment orders. If neither signal is clear, remain neutral rather than forcing a directional trade.